Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Malachia Hoover"'
Autor:
Megan Agajanian, Anaamika Campeau, Malachia Hoover, Alexander Hou, Daniel Brambilla, Sa La Kim, Richard L Klemke, Jonathan A Kelber
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135748 (2015)
Transforming Growth Factor β (TGFβ) has dual functions as both a tumor suppressor and a promoter of cancer progression within the tumor microenvironment, but the molecular mechanisms by which TGFβ signaling switches between these outcomes and the
Externí odkaz:
https://doaj.org/article/632f66d557f142b78bacd7f4bbb55c74
Autor:
Farhana Runa, Luke Tomaneng, Yvess Adamian, Nathan Cox, Albert-Fred Aquino, Matthew Wallace, Carolina Gonzalez, Kishan Bhakta, Malachia Hoover, Laurelin Wolfenden, Jonathan D. Humphries, Martin J. Humphries, Michael Boyce, Jonathan A. Kelber
Publikováno v:
Cancer Research. 82:2414-2414
Pancreatic ductal adenocarcinoma (PDAC) is associated with very poor outcomes - fewer than 10 percent of patients survive beyond five years after diagnosis. The primary hurdles facing PDAC patients and clinicians are early dissemination, a lack of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2aa31d4e9df6a93a8d2aa38502528b7
https://doi.org/10.1158/1538-7445.am2022-2414
https://doi.org/10.1158/1538-7445.am2022-2414
Autor:
Joy Lin, Julie Hong, Armen Gharibi, Daniel Brambilla, Justin Molnar, Malachia Hoover, Yvess Adamian, Jonathan A. Kelber, Laurelin Wolfenden, Sa La Kim
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Scientific Reports
Scientific Reports
Pancreatic ductal adenocarcinoma (PDAC) has single-digit 5-year survival rates at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3d617a78ec12dc83af191f58599e2f
http://link.springer.com/article/10.1038/s41598-017-09946-z
http://link.springer.com/article/10.1038/s41598-017-09946-z
Autor:
Armen Gharibi, Jason B. Fleming, Malachia Hoover, Robert M. Hoffman, Alexander Chang, Mark A. Brown, Robert Doebler, Yvess Adamian, Matthew H.G. Katz, Michael Bouvet, Ali Maawy, Jacqueline Lee, Jonathan A. Kelber
Publikováno v:
Oncotarget
Oncotarget, vol 8, iss 4
Oncotarget, vol 8, iss 4
Next-generation sequencing (NGS) can identify and validate new biomarkers of cancer onset, progression and therapy resistance. Substantial archives of formalin-fixed, paraffin-embedded (FFPE) cancer samples from patients represent a rich resource for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa7532433de38d5cc1e772b938c4b428
https://doi.org/10.18632/oncotarget.11809
https://doi.org/10.18632/oncotarget.11809
Autor:
Richard L. Klemke, Malachia Hoover, Daniel Brambilla, Anaamika Campeau, Jonathan A. Kelber, Sa La Kim, Megan Agajanian, Alexander Hou
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 8, p e0135748 (2015)
PLoS ONE, Vol 10, Iss 8, p e0135748 (2015)
Transforming Growth Factor β (TGFβ) has dual functions as both a tumor suppressor and a promoter of cancer progression within the tumor microenvironment, but the molecular mechanisms by which TGFβ signaling switches between these outcomes and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c89381c64ce835e62e4ca03d7255fff
https://pubmed.ncbi.nlm.nih.gov/26267863
https://pubmed.ncbi.nlm.nih.gov/26267863
Autor:
Joy Lin, Armen Gharibi, Yvess Adamian, Daniel Brambilla, Justin Molnar, Sa La Kim, Malachia Hoover, Jonathan A. Kelber, Julie Hong
Publikováno v:
Cancer Research. 77:LB-149
Pancreatic ductal adenocarcinoma (PDAC) remains one of few malignancies to have single-digit 5-year survival rates at Citation Format: Sa La Kim, Armen Gharibi, Justin Molnar, Daniel Brambilla, Yvess Adamian, Malachia Hoover, Joy Lin, Julie Hong, Jon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3612bb3a3263440eb9c45d6b6511ab17
https://doi.org/10.1158/1538-7445.am2017-lb-149
https://doi.org/10.1158/1538-7445.am2017-lb-149
Autor:
Ali Maawy, Robert Doebler, Malachia Hoover, Jonathan A. Kelber, Robert M. Hoffman, Michael Bouvet, Mark Brown
Publikováno v:
The FASEB Journal. 28
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Because there are virtually no biomarkers to aid in early detection or predicting therapy response, newly diagnosed patients have a dismal prognosis. Substa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fa53d91a701ce4cf3837ee71f0072e4
https://doi.org/10.1096/fasebj.28.1_supplement.1048.14
https://doi.org/10.1096/fasebj.28.1_supplement.1048.14
Autor:
Ali Maawy, Robert Doebler, Mark Brown, Michael Bouvet, Yvess Adamian, Jonathan A. Kelber, Malachia Hoover, Robert M. Hoffman
Publikováno v:
Cancer Research. 76:LB-263
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. There are virtually no biomarkers to aid in early detection or predicting therapy response, newly diagnosed patients have less than a 7% 5-year survival rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6d252e4979b4bab4a71366391fdae26
https://doi.org/10.1158/1538-7445.am2016-lb-263
https://doi.org/10.1158/1538-7445.am2016-lb-263
Autor:
Armen Gharibi, Malachia Hoover, Sa La Kim, Jonathan A. Kelber, Joy Lin, Megan Agajanian, Laurelin Wolfenden, Yvess Adamian, Daniel Brambilla
Publikováno v:
Cancer Research. 76:4426-4426
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in the United States with a five-year survival rate of approximately 7%. Its highly invasive characteristics, lack of biomarkers for early detection, limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5012a6d5c22b7dcd86fde10afe1cddaf
https://doi.org/10.1158/1538-7445.am2016-4426
https://doi.org/10.1158/1538-7445.am2016-4426